Xiangzhen R. Kong

State Key Laboratory Of Lake And Watershed Science For Water Security, 
Nanjing, CN 
State Key Laboratory Of Lake And Watershed Science For Water Security, 
Nanjing, CN 

Overview

Xiangzhen Kong practices practicing medicine in Nanjing, China.

Their clinical expertise encompasses Scleroderma, Systemic Sclerosis (SSc), Ventricular Fibrillation, Cardiac Ablation, and Kidney Transplant.

They are actively involved in clinical research, co-authoring 151 peer reviewed articles.

Locations

State Key Laboratory Of Lake And Watershed Science For Water Security, Nanjing, China
Other Locations
Wuxi, 214122, China
Shanghai, China
China
Shandong Yucheng Agro Ecosystem National Observation And Research Station, Beijing, 100101, China
Hangzhou, China
State Key Laboratory Of Food Science And Technology, Jiangnan, China
Key Laboratory Of Veterinary Chemical Drugs And Pharmaceutics, 518 Ziyue RD, Minhang, 200241, China
State Key Laboratory Of Food Science And Technology, Jiangnan University 1800 Lihu Avenue Wuxi Jiangsu Province 214122 People's Republic Of China +86-510-85329091 +86-510-85917812, Jiangnan, 859178, China
State Key Laboratory Of Urban Water Resources And Environment, Harbin, 150090, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

151 Total Publications

Corrigendum to "Gut microbiota metabolite Urolithin B inhibits chondrocyte ferroptosis by rewriting iron homeostasis via FGFR3/NCOA4/FTH1 axis, alleviating osteoarthritis" [Phytomedicine (Volume 148, 25 November 2025, 157292)].
Corrigendum to "Gut microbiota metabolite Urolithin B inhibits chondrocyte ferroptosis by rewriting iron homeostasis via FGFR3/NCOA4/FTH1 axis, alleviating osteoarthritis" [Phytomedicine (Volume 148, 25 November 2025, 157292)].
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: June 24, 2026

Frequently Asked Questions about Xiangzhen R. Kong

Is Xiangzhen R. Kong a top-rated expert for Scleroderma?

MediFind is an objective health platform that identifies experts based on real-world data. Xiangzhen R. Kong is classified as an Experienced expert for Scleroderma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Xiangzhen R. Kong participate in research or clinical trials?

Yes. Xiangzhen R. Kong has published 151 articles and abstracts on conditions like Scleroderma. You can view a list of Xiangzhen R. Kong's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Kong's expertise for a condition
ConditionClose
        View All 12 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile